| Parameters | Number of cases | Number of controls |
|---|---|---|
| Number | 66 | 44 |
| Female/male | 55/11 | 38/6 |
| Mean Age (years) ± SD | 55.85 ± 8.82 | 50.32 ± 12.44 |
| FBG (mmol/L) ± SD | 8.34 ± 3.47 | 4.75 ± 0.55 |
| Duration of Diabetes (years) ± SD | 10.67 ± 7.53 | - |
| Anti-hypertensive drugs | 39 (59.0 %) | 8 (18.1 %) |
| Patients on Metformin only | 26 (39.4 %) | - |
| Patients on Metformin plus other drugs | 57 (83.6 %) | - |
| Patients Metformin plus Glibenclamide | 16 (24.2 %) | - |
| Patients Metformin plus Insulin | 15 (22.7 %) | - |
| Patients on other drugs aside metformin | 9 (13.6) | - |